IN-VITRO EFFICACY EVALUATION OF ANTIMICROBIAL COMBINATION ON PNEUMOCOCCAL-INFECTED- COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN
Main Article Content
Abstract
Introduction: Antibiotics and combination regimens are of importance in the treatment of Community-Acquired Pneumonia (CAP). In the face of the rapid emergence of multidrug-resistant pneumococcal strains, it is necessary to re-evaluate the efficacy of combination therapies to support controlling antimicrobial resistance and selecting appropriate regimens for the treatment of CAP. Objectives: To investigate the synergistic effect of some commonly used combination therapy for the treatment of CAP on multidrug-resistant pneumococcal isolates. Methods: The experimental study was conducted to evaluate the synergistic effects of several dual antimicrobial therapies on multidrug-resistant pneumococcal isolates using E-test methods. Results: The presence of azithromycin, gentamicin reduced the MIC of antibiotics used in combination with cefotaxime, ceftriaxone on the pneumococcal strains. Gentamicin-plus-cefotaxime and gentamicin-plus-ceftriaxone combinations showed the additive antimicrobial effects on the pneumococcal strain Pca; however, there were no clear synergistic activities. Macrolide and beta-lactam combinations have not shown in vitro synergistic bactericidal effects. Conclusions: In the case of CAP induced by multidrug-resistant Streptococcus pneumoniae, combining macrolides and β-lactams does not produce in vitro synergistic effects. The clinicians should carefully consider the selection of appropriate antibiotic combinations to enhance the treatment efficacy.
Keywords
Combination therapy, in vitro, E-test, Community-Acquired Pneumonia, Streptococcus pneumoniae
Article Details
References
2. Caballero J, Rello J. Combination antibiotic therapy for community-acquired pneumonia. Annals of intensive care. 2011;1:48.
3. Larsson M, Nguyen HQ, Olson L, Tran TK, Nguyen TV, Nguyen CTK. Multi-drug resistance in Streptococcus pneumoniae among children in rural Vietnam more than doubled from 1999 to 2014. Acta Paediatrica. 2021;110(6):1916-23.
4. M07-A9 C. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Edition N, editor: Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
5. Liofilchem. MIC Test Strip Technical Sheet Synergy Testing 2016. Available from: http://www.liofilchem.net/login.area.mic/technical_sheets/MTS31.pdf.
6. M100-S21 C. Performance Standards for Antimicrobial Susceptibility Testing. Edition AS-s, editor. Wayne: Clinical and Laboratory Standards Institude; 2011.
7. Lin E, Stanek RJ, Mufson MA. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro. Antimicrobial agents and chemotherapy. 2003;47(3):1151-3.
8. Washington JA, 2nd. Discrepancies between in vitro activity of and in vivo response to antimicrobial agents. Diagnostic microbiology and infectious disease. 1983;1(1):25-31.
9. Ruppen C, Decosterd L, Sendi P. Is gentamicin necessary in the antimicrobial treatment for group B streptococcal infections in the elderly? An in vitro study with human blood products. Infectious diseases (London, England). 2017;49(3):185-92.
10. Paul M, Lador A, Grozinsky‐Glasberg S, Leibovici L. Beta lactam antibiotic monotherapy versus beta lactam‐aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database of Systematic Reviews. 2014(1).